Key Market Indicators
Belgian antacid medicine sales are expected to reach approximately $13 million by 2026. In 2021, the market was valued at $13 million, a slight 0.2% increase from the previous year. Since 2007, Belgian sales of antacid medicine have grown at an average rate of 3.4% year-on-year. In 2021, Belgium ranked fifth in the world market, overtaken by Chile with $13 million. Italy, Germany, and Chile followed in that order.
